U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Products and Medical Procedures
  4. Surgery Devices
  5. LASIK
  6. LASIK Quality of Life Collaboration Project
  1. LASIK

LASIK Quality of Life Collaboration Project

In October 2009, the FDA, the National Eye Institute (NEI), and the Department of Defense (DoD) launched the LASIK Quality of Life Collaboration Project (LQOLCP) to better understand the potential risk of severe problems that can result from LASIK. The project's goal was to develop a tool for determining the percent of patients who develop difficulties performing usual activities following LASIK, and to identify predictors for those patients.

At the time the collaboration partners developed the project, there was a limited amount of valid scientific data on certain patient-reported outcomes (PROs) related to LASIK. A PRO is a report of how patients feel and function reported by the patient, not the health care provider.

Most LASIK studies used tools, such as questionnaires, to assess visual symptoms, but only after the surgery. The Patient-Reported Outcomes with LASIK (PROWL) studies in the LQOLCP assessed visual symptoms before and after their LASIK surgery to identify changes over time. The studies also measured the impact that symptoms directly had on performing usual activities, which had not previously been done.

On this page:


Pilot

During the pilot phase, patients with various eye conditions took previously-developed paper-based and web-based questionnaires. This study showed that participants found web-based instruments for assessing PROs are easy to use and understand. This phase of the project was completed in 2011 with 118 participants.

Phase I

After expert interviews and an extensive literature search, this phase involved interviews with patients contemplating LASIK, as well as patients who had LASIK done and had experienced either poor or positive outcomes. As a result of these patient interviews, a new web-based questionnaire was developed that was easy to use, comprehensive, and understandable. This phase of the project was completed in 2011 with 22 participants.

Patient-Reported Outcomes with LASIK (PROWL)

Initial Study/PROWL-1

The PROWL-1 study was designed to evaluate newly created scales to measure visual symptoms, patient satisfaction, and expectations for and following LASIK surgery.  The study also provided an initial estimate of the prevalence of PROs in a select patient population - to estimate the percentage of patients developing difficulties performing their usual activities following LASIK. The study was conducted at the US Naval Medical Center San Diego refractive surgery clinic. This phase of the project was completed in 2014 with 262 participants.

Initial Study/PROWL-2

This study was conducted in a civilian population across the U.S. to further evaluate the newly created scales to measure visual symptoms, satisfaction and expectations for and following LASIK surgery. This phase of the project was completed in 2014 with 312 participants.

Measurement Tool

The project produced a questionnaire (see links below) with new scales that can be used to more thoroughly assess candidates’ symptoms before LASIK surgery, monitor them for visual symptoms as well as satisfaction after LASIK surgery, and measure the impact any post-LASIK symptoms have on a patient’s ability to function. The questionnaire also includes images and clear definitions for the visual symptoms (ghosting/double vision, halos, glare, and starbursts). In addition to a literature search and expert interviews, we conducted focus groups with patients and cognitive interviews to develop the new scales.

The questionnaire also included previously-developed scales for evaluating dry eye symptoms and night driving difficulties. Each of these scales can be used in further research to identify patients more likely to experience serious difficulties.

Investigators may select the most relevant scales for their research questions.  Since some of the questions measure similar things, the questionnaire is not meant to be used in its entirety in future clinical studies.  Patients and health care providers now have a well-defined tool to guide medical decision making and future research. 

The PROWL Pre-Op Questionnaire can be used to more thoroughly assess candidates’ symptoms before LASIK surgery. The PROWL Post-op Questionnaire can be used to monitor patients for visual symptoms as well as satisfaction after LASIK surgery, and measure the impact any post-LASIK symptoms have on a patient’s ability to function.

For more information on the scales and questions used in the PROWL studies to aid health care providers in sleeting the most approrpate scales, see Items included in the PROWL Questionnaire (PDF-63KB).

PROWL Pre-op Questionnaire

PROWL Post-op Questionnaire

Study Results

The problems some study participants developed after having LASIK surgery, such as difficulty driving at night, severely impacted a patient’s daily living, and included debilitating vision symptoms (seeing starbursts, glare, ghosting, or halos) and severe dry eye. In each of the PROWL studies, less than 1 percent of patients experienced difficulty performing usual activities following LASIK surgery due to any one symptom.

When LQOLCP was designed, the collaboration partners intended to conduct a larger study to identify predictors for those patients who develop difficulties performing their usual activities following LASIK. Given the findings of so few patients experiencing debilitating symptoms, a very large clinical study would be necessary to estimate the prevalence more accurately and find useful predictors for these patients. Although the LQOLCP partners have made the questionnaire publicly available, resource limitations prevent the FDA from conducting a study of this size.

Based on further analyses of the studies conducted as part of the LQOLCP:

  • Up to 46 percent of participants, who had no visual symptoms before surgery, reported at least one visual symptom at three months after surgery.
  • Participants who developed new visual symptoms after surgery, most often developed halos. Up to 40 percent of participants with no halos before LASIK had halos three months following surgery.
  • Up to 28 percent of participants with no symptoms of dry eyes before LASIK, reported dry eye symptoms at three months after their surgery. This is consistent with previous studies.
  • Less than 1 percent of study participants experienced "a lot of difficulty" with or inability to do usual activities without corrective lenses because of any one visual symptom (starbursts, ghosting, halos, glare) after LASIK surgery.
  • More than 95% of participants were satisfied with their vision following LASIK surgery.
  • Participants were more than twice as likely to report their visual symptoms on a questionnaire than to tell them to their health care provider

PROWL-Symptoms and Satisfaction with Vision

The Patient-Reported Outcomes with LASIK Symptom and Satisfaction (PROWL-SS) questionnaire is qualified under the FDA’s Medical Device Development Tool (MDDT) program. The PROWL-SS assesses the existence, bothersomeness, and impact of four visual symptoms (double images, glare, haloes, and starburst) and satisfaction with vision in patients undergoing LASIK surgery.

An MDDT is scientifically validated, can be qualified for use in device evaluation, and used to support regulatory decision-making. Qualification means that the FDA has evaluated the tool. The FDA concurs with the available supporting evidence provided by the sponsor of the tool showing that the tool produces scientifically plausible measurements, and that it works as intended within the specified context of use.

For information on qualification of the PROWL-SS, see the Summary of Evidence and Basis of Qualification (SEBQ) Decision for the PROWL-SS (PDF-##KB). For details on the MDDT program, see Medical Device Development Tools (MDDT).

Publications

Presentations

LASIK Quality of Life Collaboration Project: Study Results Presentations at a Symposium of the American Academy of Ophthalmology (AAO)

Back to Top